New Drug Provides Novel Benefit for Student Battling Genetic Disorder

All video content available for media use.

To download broadcast-quality video and scripts, click on the links above. Once asset is chosen, the download arrow is in the bottom right hand corner.

Story Summary

As a little girl, Abigail Morrall was told to live in the moment, as her life expectancy didn’t venture far into adulthood. But at the age of 23, she may be getting the miracle she always prayed for in the form of a medication to stall the progression of her genetic disease.

Abigail has started taking Spinraza — the first FDA-approved drug for spinal muscular atrophy.

Please contact us with any questions or issues.

Kent Faddis
Video Content Manager
MU Health Care
Office: 573-884-0532
Cell: 573-823-9499 
faddisk@health.missouri.edu

Megan Noe
Video Content Producer
MU Health Care
Office: 573-884-0512
Cell: 309-721-9885
noemm@health.missouri.edu